Lawrence Boise

36.4k citations

235 papers · 20.5k indexed · 7 hit papers · h-index 67

Impact in

Hematology top 0.2%
- Multiple Myeloma Research and Treatments
Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Hematology 111
- Multiple Myeloma Research and Treatments 104
Oncology 71
- Cancer Treatment and Pharmacology 16

Co-authors: Craig B. Thompson Andy J. Minn Elizabeth Yang Gabriel Núñez Li-Yun Ding Maribel González‐García Tullia Lindsten Xiaohong Mao
Journals: Blood (71 papers)Journal of Clinical Oncology (9 papers)Journal of Biological Chemistry (8 papers)Molecular and Cellular Biology (7 papers)Proceedings of the National Academy of Sciences (6 papers)
Partner nations: United States Canada France

In The Last Decade

Lawrence Boise

224 papers receiving 20.2k citations

Hit Papers

7 papers align trajectories log scale

Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis 2013 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 BMC Cell Biology
2006 Blood
1995 Proceedings of the National Academy of Sciences
1995 Cell
1995 Immunity
1994 Proceedings of the National Academy of Sciences
1993 Cell

Peers

Countries citing papers authored by Lawrence Boise

Since Specialization

Citations

This map shows the geographic impact of Lawrence Boise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Boise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Boise more than expected).

Fields of papers citing papers by Lawrence Boise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Boise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Boise. The network helps show where Lawrence Boise may publish in the future.

Co-authors

The 25 scholars most cited alongside Lawrence Boise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence Boise Line = papers co-authored together Lawrence Boise links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	KDM6A regulates immune response genes in multiple myeloma Blood ·Kouhei Sugita, Alberto Riva, Benjamin G. Barwick, Sayantan Maji, Chen Jun-na, Jianping Li, Umasankar De, Amin Sobh, Lib Web, Sara Japhet, Marta Kulis, Teresa Ezponda, José I. Martı́n-Subero, Giovanni Tonon, Weizhou Zhang, Constantine S. Mitsiades, Lawrence Boise, Richard L. Bennett, Jonathan D. Licht	2024	5
2	Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors Cancer Research Communications ·煥江李, Roberta Buono, Shannon M. Matulis, Vikas A. Gupta, 幸子三井, WILLIAM H. HUDNUT, Messrs. M. John Robinson, Sharmila Mallya, Daryono, E. Ruiz Muñoz, Tian Jianhui, Yuliana Torres Blanco, Vy M. Dong, Andrew W. Roberts, Joel Johansson, Marc Raboy, A. B. udou, Orlando F. Bueno, Lawrence Boise, (unknown)	2023	3
3	PDZ Proteins SCRIB and DLG1 Regulate Myeloma Cell Surface CD86 Expression, Growth, and Survival Molecular Cancer Research ·Hanna Kurlanda-Witek, Younes Belabbas, Benjamin G. Barwick, Anita De Grave, Lawrence Boise	2022	5
4	Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma Science Advances ·Gary Simpson, Remya Nair, Abhinav Achreja, Anjali Mittal, Pulkit Gupta, Quinche Moreira, Xiaosheng Zhao, Olamide Animasahun, Bhakti Dwivedi, Benjamin G. Barwick, Vikas A. Gupta, Shannon M. Matulis, Manoj Bhasin, Sagar Lonial, Ajay K. Nooka, Arun P. Wiita, Lawrence Boise, Deepak Nagrath, Mala Shanmugam	2022	12
5	Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients Cancers ·C. L. Costales, Eric B. Dammer, R A SANDISON, Eva Fresco, 藤田直久, Guillermo Campoverde Parihuaman, S. Hayashiguchi, Fengxia Yan, Sanjay Jain, Benjamin G. Barwick, Rajesh Singh, Lawrence Boise, James W. Lillard	2022	3
6	Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia Blood Cancer Discovery ·Akhilesh Kaushal, Ajay K. Nooka, Llc DreamSaver Enterprises, Katherine E. Pendleton, Benjamin G. Barwick, Yeshi Wang, Samuel S. McCachren, Vikas A. Gupta, Nisha S. Joseph, Craig C. Hofmeister, Jonathan L. Kaufman, Leonard T. Heffner, Stephen M. Ansell, Lawrence Boise, Sagar Lonial, Kavita M. Dhodapkar, Madhav V. Dhodapkar	2021	14
7	Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma Clinical Cancer Research ·Benjamin G. Barwick, Vikas A. Gupta, Shannon M. Matulis, 焦飞, Doris R. Powell, Yanyan Gu, David L. Jaye, Karen N. Conneely, Yin C. Lin, Craig C. Hofmeister, Ajay K. Nooka, Jonathan J. Keats, Sagar Lonial, Paula M. Vertino, Lawrence Boise	2021	10
8	Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma Journal of Clinical Oncology ·Nisha S. Joseph, Jonathan L. Kaufman, Madhav V. Dhodapkar, Craig C. Hofmeister, Ö T Z Maya, Leonard T. Heffner, Vikas A. Gupta, Lawrence Boise, Sagar Lonial, Ajay K. Nooka	2020	132
9	Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma Nature Communications ·Richa Bajpai, Aditi Sharma, Abhinav Achreja, Xiaosheng Zhao, Changyong Wei, Stefani A. Schomaker, Vikas A. Gupta, Shannon M. Matulis, Samuel K. McBrayer, Anjali Mittal, Manali Rupji, Benjamin G. Barwick, Sagar Lonial, Ajay K. Nooka, Lawrence Boise, Deepak Nagrath, Mala Shanmugam	2020	76
10	Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma Blood Advances ·Yu-Hsiu T. Lin, Gregory P. Way, Benjamin G. Barwick, T. Terkenli, Ulrike Pohlmann, Ian Ferguson, Christoph Driessen, Lawrence Boise, Casey S. Greene, Arun P. Wiita	2019	14
11	Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy JCI Insight ·Jithendra Kini Bailur, Samuel S. McCachren, Deon B. Doxie, Mahesh Shrestha, Katherine E. Pendleton, Ajay K. Nooka, Natalia Neparidze, Terri L. Parker, Noffar Bar, Jonathan L. Kaufman, Craig C. Hofmeister, Lawrence Boise, Sagar Lonial, Melissa L. Kemp, Kavita M. Dhodapkar, Madhav V. Dhodapkar	2019	117
12	Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents Cancer ·Roberto Mina, Nisha S. Joseph, Jonathan L. Kaufman, Vikas A. Gupta, Leonard T. Heffner, Craig C. Hofmeister, Lawrence Boise, Madhav V. Dhodapkar, Charise Gleason, Ajay K. Nooka, Sagar Lonial	2018	34
13	Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM) Blood ·Nisha S. Joseph, Ö T Z Maya, Charise Gleason, Leonard T. Heffner, Lawrence Boise, Jonathan L. Kaufman, Sagar Lonial, Ajay K. Nooka	2017	0
14	High-Risk Myeloma Is Demarcated By Immunoglobulin Lambda Light Chain Translocations Blood ·Benjamin G. Barwick, Vikas A. Gupta, Daniel Auclair, Jonathan J. Keats, Sagar Lonial, Paula M. Vertino, Lawrence Boise	2017	1
15	Phase 1 Study of Venetoclax in Combination with Dexamethasone As Targeted Therapy for t(11;14) Relapsed/Refractory Multiple Myeloma Blood ·Jonathan L. Kaufman, Cristina Gasparetto, Joseph Mıkhael, Philippe Moreau, Cyrille Touzeau, Ravi Vij, Thierry Façon, Brigitte Pegourié, Lofti Benboubker, Lawrence Boise, Stefanie Alzate, Martin Dunbar, Jia Jia, Kevin J. Freise, Maria Verdugo, Jeremy A. Ross, Paulo Maciag, Shaji Kumar	2017	12
16	Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM) Blood ·Paola Neri, Ranjan Maity, M Moghadassi Risseh, Peter Duggan, Γεωργία Ακριβοπούλου, Víctor H. Jiménez‐Zepeda, Jason Tay, Lawrence Boise, Anjan Thakurta, Nizar J. Bahlis	2017	15
17	Role of Cytochrome c in Apoptosis: Increased Sensitivity to Tumor Necrosis Factor Alpha Is Associated with Respiratory Defects but Not with Lack of Cytochrome c Release Molecular and Cellular Biology ·Uma D. Vempati, Francisca Díaz, Antoni Barrientos, Sonoko Narisawa, A. Mohsin Mian, José Luís Millán, Lawrence Boise, Carlos T. Moraes	2007	51
18	Bortezomib Inhibits PKR-Like Endoplasmic Reticulum (ER) Kinase and Induces Apoptosis via ER Stress in Human Pancreatic Cancer Cells Cancer Research ·Steffan T. Nawrocki, Jennifer S. Carew, Kenneth Dunner, Lawrence Boise, Paul J. Chiao, Peng Huang, James L. Abbruzzese, David J. McConkey	2005	260
19	Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway Journal of Biological Chemistry ·Monika Jost, Abhyudy Mandal, Csaba Kari, Lawrence Boise, Ulrich Rodeck	2001	123
20	The NFAT-1 DNA Binding Complex in Activated T Cells Contains Fra-1 and JunB Molecular and Cellular Biology ·Lawrence Boise, Bronislawa Petryniak, Xiaohong Mao, Carl H. June, Rolinskyi Oleksandr V., Tullia Lindsten, Rodrigo Bravo, Karla Kovary, Jeffrey M. Leiden, Craig B. Thompson	1993	202

About Lawrence Boise

Lawrence Boise is a scholar working on Hematology, Oncology, Molecular Biology, Immunology and Cancer Research, having authored 235 papers that have together received 20.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (104 papers), Cell death mechanisms and regulation (51 papers), Protein Degradation and Inhibitors (47 papers), Ubiquitin and proteasome pathways (24 papers), Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (17 papers), Retinoids in leukemia and cellular processes (16 papers) and Cancer Treatment and Pharmacology (16 papers). The work is most often cited by research in Hematology (2.9k citations), Immunology (5.2k citations), Molecular Biology (13.0k citations), Oncology (5.0k citations) and Cancer Research (2.0k citations). Lawrence Boise has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Craig B. Thompson, Andy J. Minn, Elizabeth Yang, Gabriel Núñez, Li-Yun Ding, Maribel González‐García, Tullia Lindsten, Xiaohong Mao, Stanley J. Korsmeyer and Jennifer Jockel. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Biological Chemistry, Molecular and Cellular Biology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact